These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 30276829)

  • 1. Letter to Editor: Response to AASLD Editorial/Message from the President.
    Koretz RL; Jakobsen JC; Hauser G; Nikolova D; Gluud C
    Hepatology; 2019 May; 69(5):2300. PubMed ID: 30276829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reply.
    Lok AS; Powderly WG
    Hepatology; 2019 May; 69(5):2301. PubMed ID: 30762891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study.
    Colussi G; Donnini D; Brizzi RF; Maier S; Valenti L; Catena C; Cavarape A; Sechi LA; Soardo G
    World J Gastroenterol; 2019 Oct; 25(40):6094-6106. PubMed ID: 31686765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors Associated with Increase in Skeletal Muscle Mass after Sustained Virological Response in Chronic Hepatitis C Treated with Direct Acting Antivirals.
    Yoh K; Nishikawa H; Enomoto H; Ishii A; Iwata Y; Miyamoto Y; Ishii N; Yuri Y; Hasegawa K; Nakano C; Nishimura T; Aizawa N; Sakai Y; Ikeda N; Takashima T; Takata R; Iijima H; Nishiguchi S
    Nutrients; 2017 Oct; 9(10):. PubMed ID: 29057827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct antiviral treatment of chronic hepatitis C in heart transplant recipients.
    Vitrone M; Andini R; Mattucci I; Maiello C; Atripaldi L; Durante-Mangoni E; Zampino R
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29139181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct acting antivirals failure: cause and retreatment options.
    Parlati L; Pol S
    Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1245-1250. PubMed ID: 30791789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients.
    Calogero A; Sagnelli E; Creta M; Angeletti S; Peluso G; Incollingo P; Candida M; Minieri G; Carlomagno N; Dodaro CA; Ciccozzi M; Sagnelli C
    Biomed Res Int; 2019; 2019():4674560. PubMed ID: 31179323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of sustained virological response by direct-acting antivirals on insulin resistance and diabetes mellitus in patients with chronic hepatitis C.
    Adinolfi LE; Rinaldi L; Marrone A; Giordano M
    Expert Rev Anti Infect Ther; 2018 Aug; 16(8):595-597. PubMed ID: 30047799
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of Interferon-Free Therapies for Chronic Hepatitis C: A Systematic Review of All Randomized Clinical Trials.
    Ferreira VL; Tonin FS; Assis Jarek NA; Ramires Y; Pontarolo R
    Clin Drug Investig; 2017 Jul; 37(7):635-646. PubMed ID: 28409482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-free therapies for patients with chronic hepatitis C genotype 3 infection: A systematic review.
    Gimeno-Ballester V; Buti M; San Miguel R; Riveiro M; Esteban R
    J Viral Hepat; 2017 Nov; 24(11):904-916. PubMed ID: 27925386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular Carcinoma after Achievement of Sustained Viral Response with Daclatasvir and Asunaprevir in Patients with Chronic Hepatitis C Virus Infection.
    Ida H; Hagiwara S; Kono M; Minami T; Chishina H; Arizumi T; Takita M; Yada N; Minami Y; Ueshima K; Nishida N; Kudo M
    Dig Dis; 2017; 35(6):565-573. PubMed ID: 29040989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study.
    Romano A; Angeli P; Piovesan S; Noventa F; Anastassopoulos G; Chemello L; Cavalletto L; Gambato M; Russo FP; Burra P; Vincenzi V; Scotton PG; Panese S; Tempesta D; Bertin T; Carrara M; Carlotto A; Capra F; Carolo G; Scroccaro G; Alberti A
    J Hepatol; 2018 Aug; 69(2):345-352. PubMed ID: 29551707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review: epidemiology and response to direct-acting antiviral therapy in genotype 6 chronic hepatitis C virus infection.
    Mettikanont P; Bunchorntavakul C; Reddy KR
    Aliment Pharmacol Ther; 2019 Mar; 49(5):492-505. PubMed ID: 30687952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. American Gastroenterological Association Institute Clinical Practice Update-Expert Review: Care of Patients Who Have Achieved a Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C Infection.
    Jacobson IM; Lim JK; Fried MW
    Gastroenterology; 2017 May; 152(6):1578-1587. PubMed ID: 28344022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: are additional tests needed to predict sustained virologic response in hepatitis C treated with interferon-free direct-acting antiviral combinations?
    Ferenci P
    Aliment Pharmacol Ther; 2018 Mar; 47(6):848-849. PubMed ID: 29446143
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver Cirrhosis.
    Toshikuni N
    Gut Liver; 2017 May; 11(3):335-348. PubMed ID: 27840363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What Are the Benefits of a Sustained Virologic Response to Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection?
    Ioannou GN; Feld JJ
    Gastroenterology; 2019 Jan; 156(2):446-460.e2. PubMed ID: 30367836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribavirin steady-state plasma level is a predictor of sustained virological response in hepatitis C-infected patients treated with direct-acting antivirals.
    van Tilborg M; Lieveld FI; Smolders EJ; van Erpecum KJ; de Kanter CTMM; Maan R; van der Valk M; Arends JE; Dofferhoff ASM; Blokzijl H; Bijmolen M; Drenth JPH; de Knegt RJ; Burger DM;
    Aliment Pharmacol Ther; 2017 Nov; 46(9):864-872. PubMed ID: 28881031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on hepatitis C treatment: systematic review of clinical trials.
    Jhaveri M; Procaccini N; Kowdley KV
    Minerva Gastroenterol Dietol; 2017 Mar; 63(1):62-73. PubMed ID: 27768010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV-positive lymphoma after sustained virological response with direct-acting antiviral agents: The game is not over after HCV eradication.
    Rodríguez de Santiago E; Velázquez Kennedy K; García González M; Gea Rodríguez F; Téllez Villajos L; Tavío Hernández E; Albillos A
    J Viral Hepat; 2018 May; 25(5):614-615. PubMed ID: 29239080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.